Protara Therapeutics, Inc. (TARA)
3.82
+0.03
(+0.79%)
USD |
NASDAQ |
Sep 11, 16:00
3.83
+0.01
(+0.26%)
After-Hours: 20:00
Protara Therapeutics Price : 3.82 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 3.83 | 3.95 | 3.81 | 3.82 | 532026.0 |
| Sep 10, 2026 | 3.83 | 3.83 | 3.735 | 3.79 | 467373.0 |
| Sep 09, 2026 | 3.86 | 3.945 | 3.83 | 3.83 | 287160.0 |
| Sep 08, 2026 | 3.92 | 3.955 | 3.83 | 3.89 | 385700.0 |
| Sep 04, 2026 | 3.93 | 3.96 | 3.89 | 3.94 | 203007.0 |
| Sep 03, 2026 | 3.94 | 3.98 | 3.87 | 3.97 | 239457.0 |
| Sep 02, 2026 | 3.92 | 4.000 | 3.855 | 3.94 | 335411.0 |
| Sep 01, 2026 | 3.81 | 3.915 | 3.795 | 3.90 | 222411.0 |
| Aug 31, 2026 | 3.79 | 3.88 | 3.72 | 3.86 | 506469.0 |
| Aug 28, 2026 | 3.99 | 3.99 | 3.785 | 3.82 | 399079.0 |
| Aug 27, 2026 | 3.93 | 4.04 | 3.90 | 3.99 | 256803.0 |
| Aug 26, 2026 | 3.96 | 4.05 | 3.88 | 3.91 | 763154.0 |
| Aug 25, 2026 | 3.87 | 3.99 | 3.86 | 3.97 | 272735.0 |
| Aug 24, 2026 | 3.84 | 3.89 | 3.715 | 3.87 | 229882.0 |
| Aug 21, 2026 | 3.91 | 3.95 | 3.81 | 3.85 | 238444.0 |
| Aug 20, 2026 | 3.92 | 3.93 | 3.83 | 3.90 | 360848.0 |
| Aug 19, 2026 | 4.06 | 4.115 | 3.95 | 3.96 | 359704.0 |
| Aug 18, 2026 | 3.97 | 4.02 | 3.885 | 3.98 | 335973.0 |
| Aug 17, 2026 | 3.96 | 4.01 | 3.93 | 3.98 | 268083.0 |
| Aug 14, 2026 | 3.94 | 4.00 | 3.83 | 3.97 | 333295.0 |
| Aug 13, 2026 | 3.91 | 3.995 | 3.85 | 3.94 | 309945.0 |
| Aug 12, 2026 | 4.00 | 4.026 | 3.78 | 3.89 | 467688.0 |
| Aug 11, 2026 | 4.00 | 4.03 | 3.85 | 3.91 | 618115.0 |
| Aug 10, 2026 | 4.11 | 4.17 | 4.07 | 4.11 | 281175.0 |
| Aug 07, 2026 | 4.13 | 4.175 | 4.005 | 4.12 | 340659.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| NovelStem International Corp. | 0.0095 |
| Brainstorm Cell Therapeutics, Inc. | 1.08 |
| Summit Therapeutics, Inc. | 17.55 |
| Kezar Life Sciences, Inc. | 7.29 |
| Clene, Inc. | 3.57 |
Price Related Metrics
| Price to Book Value | 1.399 |
| Earnings Yield | -35.44% |
| Market Cap | 225.70M |